CHU - La Milétrie Poitiers France.
UMR-CNRS 7267 Université de Potiers France.
FEBS Open Bio. 2019 Mar 15;9(4):736-742. doi: 10.1002/2211-5463.12610. eCollection 2019 Apr.
We previously reported that exclusively breastfed infants born to mothers with pregestational obesity gain less weight during the first month after birth than those born to mothers of normal pregestational weight. This issue is potentially important since lower weight gain in breastfed infants of obese mothers might increase the risk of developing later obesity. Breast milk quality and quantity, together with breastfeeding practice, possibly influence infants' feeding behavior, appetite control, and regulation of growth later in life. The issue of whether breast milk protein patterns from obese mothers differ in composition from those of non-obese mothers remains largely unexplored. Here, we established a breast milk proteomic pattern that discriminates obese mothers and infants with delayed weight gain at 1 month after birth from normal-weight mothers with infants of the same age and with normal weight gain. Obese mothers were matched to normal-weight mothers ( = 26; body mass index 33.5 ± 3.2 21.5 ± 1.5 kg·m). The mean weight gain of infants in the obese group at 1 month after birth was 430.8 g lower than that of the infants in the control group. Analysis of the breast milk delipidized fraction by surface-enhanced laser desorption/ionization on CM10 and Q10 arrays was followed by MS-assisted purification and LC-MS/MS microsequencing of a selected biomarker. We identified 15 candidate protein biomarkers, seven of which were overexpressed in the obese group and eight in the normal-weight group. One of the most significant candidate biomarkers, overexpressed in the obese group, was identified as a fragment of the sixth extracellular domain of the polymeric immunoglobulin receptor. Further structural identification of these candidate biomarkers and their validation in clinical assays may facilitate the development of a predictive immunoassay.
我们之前曾报道,与正常体质量孕前母亲所生婴儿相比,孕前肥胖母亲所生的纯母乳喂养婴儿在出生后第一个月体重增加较少。这个问题可能很重要,因为肥胖母亲母乳喂养婴儿体重增加较少可能会增加日后肥胖的风险。母乳的质量和数量,以及母乳喂养的方式,可能会影响婴儿的喂养行为、食欲控制和日后的生长发育。肥胖母亲的母乳蛋白质组成是否与非肥胖母亲的母乳蛋白质组成不同,这个问题在很大程度上仍未得到探索。在这里,我们建立了一种母乳蛋白质组模式,可以区分肥胖母亲和出生后 1 个月体重增长缓慢的婴儿,以及体重正常的母亲和具有正常体重增长的同龄婴儿。肥胖母亲与正常体重母亲相匹配(n=26;体重指数 33.5±3.2 vs. 21.5±1.5 kg·m)。出生后 1 个月,肥胖组婴儿的平均体重增加量比对照组婴儿低 430.8 g。通过表面增强激光解吸/电离在 CM10 和 Q10 阵列上对脱脂母乳进行分析,然后进行 MS 辅助纯化和选定生物标志物的 LC-MS/MS 微测序。我们鉴定出 15 种候选蛋白生物标志物,其中 7 种在肥胖组中表达上调,8 种在正常体重组中表达上调。其中一个最显著的候选生物标志物在肥胖组中表达上调,被鉴定为多聚免疫球蛋白受体第六个细胞外结构域的片段。这些候选生物标志物的进一步结构鉴定及其在临床检测中的验证,可能有助于开发预测性免疫检测方法。